Major Metformin recalls underway

June 08, 2020

Five pharma markers are recalling the diabetes medication due to the presence of a carcinogenic ingredient.

Express Scripts Report: Top Drug Classes Driving Spending Growth

February 25, 2020

Express Scripts’ annual Drug Trend Report highlights top contributors to prescription drug spending in 2019.

More Ranitidine recalled, plus another big drug recall

January 10, 2020

Major depression drug recalled over wrong dosage.

Pfizer slashes prices as most pharma makers hike prices in new year

January 03, 2020

Pfizer bucks the trend with as high as 98.5% price cuts.

FDA clears first-in-class migraine drug

January 03, 2020

Approval of Ubrelvy follows several new migraine drugs.

Gilead snags approval for second HIV-1 prevention drug

October 07, 2019

New HIV prevention drug not indicated for women.

FDA approval given for new drug to treat obesity

September 15, 2014

FDA has approved a combination of the generic drugs naltrexone and bupropion (Contrave) for chronic weight management in obese adults (body mass index [BMI] >30 kg/m2). This combination agent has also been approved for use in those patients who are overweight (BMI >27 kg/m2) and have at least one weight-related comorbid condition such as diabetes, hypertension, or dyslipidemia.

Study: Hep C drugs could increase Medicare Part D spending in 2015

August 12, 2014

The federal government’s cost for Medicare Part D will increase between $2.9 billion and $5.8 billion if we see 15% to 30% of hepatitis C (HCV)-infected beneficiaries receive treatment in 2015 and the cost of treatment averages $84,000, according to a new study by Milliman.

Age restriction on emergency contraception lifted

April 10, 2013

On April 5, a US District Court judge ruled that the emergency contraception (EC) pill Plan B One-Step must be made available over-the-counter to all girls and women, regardless of their age. This ruling, made by Judge Edward R. Korman, was in response to a 2011 move by Health and Human Services Secretary Kathleen Sebelius.

Judge orders FDA to make emergency contraceptive available without prescription for all ages

April 05, 2013

A New York federal judge has struck down the restrictions on levonorgestrel-based emergency contraceptives and ordered the FDA to make the drugs available without a prescription and without point-of-sale or age restrictions within 30 days, according to an April 4th memorandum and order